Symbol not found

NASDAQ:GMDA   00:00AM GMT
0.00
0.00 (0.00%)
Products

Gamida Cell Announces FDA Acceptance Of Biologics License Application For Omidubicel With Priority Review

Published: 08/01/2022 12:07 GMT
Gamida Cell Ltd (GMDA) - Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel With Priority Review.
Gamida Cell Ltd- PDUFA Target Action Date is January 30, 2023.